Literature DB >> 22027872

Long-term impact of the Kenya postelection crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya.

Rachel B Yoder1, Winstone M Nyandiko, Rachel C Vreeman, Samwel O Ayaya, Peter O Gisore, Paula Braitstein, Sarah E Wiehe.   

Abstract

BACKGROUND: Kenya experienced a political and humanitarian crisis after presidential elections on December 27, 2007. We sought to describe both the immediate and long-term impact of this conflict for HIV-infected children in western Kenya.
METHODS: We conducted a retrospective study of a cohort of these children for 3 periods: period 1, before the election (October 26, 2007, to December 25, 2007); period 2, immediately after the election (December 26, 2007, to April 15, 2008); and period 3, long-term postelection (April 16, 2008, to December 31, 2008). Two outcome variables of loss-to-follow-up (LTFU) were assessed: initial LTFU and complete LTFU. We assessed clinic adherence by evaluating the difference between actual visits and expected visits. Among children on antiretroviral therapy (ART), we assessed overall medication adherence and changes in medication adherence.
RESULTS: Two thousand five hundred forty-nine HIV-infected children <14 years were seen in period 1. Children on ART had less initial LTFU (3.0% compared with 5.1%, P < 0.01) and less complete LTFU (2.6% compared with 6.8%, P < 0.001) than children not on ART. For children not on ART, clinic adherence improved in period 3 compared with period 2. For children on ART with a more strict measure of clinic adherence, clinic adherence declined over time. Orphans had better clinic adherence than nonorphans. Among children on ART, there were few demographic differences when comparing medication adherence between time.
CONCLUSIONS: HIV-infected children are at risk for disruptions in clinic follow-up and medication adherence after a humanitarian crisis. Individual and contextual factors moderate the effects of these disruptions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22027872     DOI: 10.1097/QAI.0b013e31823b4448

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  11 in total

1.  Impact of the Ebola epidemic on general and HIV care in Macenta, Forest Guinea, 2014.

Authors:  David Leuenberger; Jean Hebelamou; Stefan Strahm; Nathalie De Rekeneire; Eric Balestre; Gilles Wandeler; François Dabis
Journal:  AIDS       Date:  2015-09-10       Impact factor: 4.177

2.  Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals.

Authors:  Livio Azzoni; Andrea S Foulkes; Cynthia Firnhaber; Xiangfan Yin; Zhi Q Xiang; Yan Li; Wendy Stevens; Robert Gross; Hildegund C J Ertl; Ian Sanne; Luis J Montaner
Journal:  AIDS       Date:  2012-07-17       Impact factor: 4.177

3.  Antiretroviral treatment interruptions induced by the Kenyan postelection crisis are associated with virological failure.

Authors:  Marita Mann; Lameck Diero; Emmanuel Kemboi; Fidelis Mambo; Mary Rono; Wilfred Injera; Allison Delong; Leeann Schreier; Kara W Kaloustian; John Sidle; Nathan Buziba; Rami Kantor
Journal:  J Acquir Immune Defic Syndr       Date:  2013-10-01       Impact factor: 3.731

Review 4.  A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS.

Authors:  Sera Young; Amanda C Wheeler; Sandra I McCoy; Sheri D Weiser
Journal:  AIDS Behav       Date:  2014-10

Review 5.  Scale-up of HIV treatment through PEPFAR: a historic public health achievement.

Authors:  Wafaa M El-Sadr; Charles B Holmes; Peter Mugyenyi; Harsha Thirumurthy; Tedd Ellerbrock; Robert Ferris; Ian Sanne; Anita Asiimwe; Gottfried Hirnschall; Rejoice N Nkambule; Lara Stabinski; Megan Affrunti; Chloe Teasdale; Isaac Zulu; Alan Whiteside
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

6.  Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.

Authors:  Valeriane Leroy; Karen Malateste; Helena Rabie; Pagakrong Lumbiganon; Samuel Ayaya; Fatoumata Dicko; Mary-Ann Davies; Azar Kariminia; Kara Wools-Kaloustian; Edmond Aka; Samuel Phiri; Linda Aurpibul; Constantin Yiannoutsos; Haby Signaté-Sy; Lynne Mofenson; François Dabis
Journal:  J Acquir Immune Defic Syndr       Date:  2013-02-01       Impact factor: 3.731

7.  Evaluations of reproductive health programs in humanitarian settings: a systematic review.

Authors:  Sara E Casey
Journal:  Confl Health       Date:  2015-02-02       Impact factor: 2.723

8.  High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study.

Authors:  Christian Diamant Mossoro-Kpinde; Jean-Chrysostome Gody; Ralph-Sydney Mboumba Bouassa; Olivia Mbitikon; Mohammad-Ali Jenabian; Leman Robin; Mathieu Matta; Kamal Zeitouni; Jean De Dieu Longo; Cecilia Costiniuk; Gérard Grésenguet; Ndèye Coumba Touré Kane; Laurent Bélec
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

9.  Adherence to antiretroviral therapy in a clinical cohort of HIV-infected children in East Africa.

Authors:  Rachel C Vreeman; Samuel O Ayaya; Beverly S Musick; Constantin T Yiannoutsos; Craig R Cohen; Denis Nash; Deo Wabwire; Kara Wools-Kaloustian; Sarah E Wiehe
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

10.  Delivery of HIV care during the 2007 post-election crisis in Kenya: a case study analyzing the response of the Academic Model Providing Access to Healthcare (AMPATH) program.

Authors:  Suzanne Goodrich; Samson Ndege; Sylvester Kimaiyo; Hosea Some; Juddy Wachira; Paula Braitstein; John E Sidle; Jackline Sitienei; Regina Owino; Cleophas Chesoli; Catherine Gichunge; Fanice Komen; Claris Ojwang; Edwin Sang; Abraham Siika; Kara Wools-Kaloustian
Journal:  Confl Health       Date:  2013-12-01       Impact factor: 2.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.